Primary malignant non-Hodgkin’s lymphoma of the breast: a study of seven cases and literature review
Primary breast lymphoma is an uncommon disease with poor clinical outcome. Breast lymphomas present less than 0.5% of malignant breast neoplasms and 2.2% of extranodal lymphomas. This study investigated the clinicopathological features and optimal treatment of PBL.
Clinical records of seven Moroccan PBL patients, treated at the National Institute of Oncology, Rabat, Morocco, from 2002 to 2010, were reviewed. Six of the patients were women and one a man, with ages ranging from 32 to 76. Five patients had stage IE and two stage IIE. All of the patients were classified with DLBCL. Of seven patients, one received a mastectomy and three excision of the breast lesion. Axillary dissection was performed in three patients. Two patients received chemotherapy followed by radiotherapy, while four received chemotherapy alone. Complete remission (CR) following primary treatment for all patients with PBL except in two cases was obtained. In one patient, recurrence occurred.
There is no consensus on the question of how to best treat PBL: Mastectomy offers no benefit in the treatment of PBL. The combined therapy approach, with chemotherapy and radiotherapy, is the most successful treatment. PBL is poorly represented in rituximab-containing trials in DLBCL patients; there is not much experience with this agent in breast DLBCL. Because of the high incidence of central nervous system (CNS) involvement in PBL patients, many authors strongly believe that patients with aggressive forms of PBL should receive CNS infiltration prophylaxis.
- Jinming X, Qi Z, Xiaoming Z, Jianming T: Primary non-Hodgkin’s lymphoma of the breast: mammography, ultrasound, MRI and pathologic findings. Futur Oncol 2012,8(1):105–109. CrossRef
- Wiseman C, Liao KT: Primary lymphoma of the breast. Cancer 1972,29(6):1705. CrossRef
- Tavassoli FA, Devilee P: WHO classification of tumours: pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon; 2003.
- Carbone PP, Kaplan HS, Mushoff K, Smithers DW, Tubiana M: Report of the committee on Hodgkin’s disease classification. Cancer Res 1971, 31:1860–1861.
- Nicola A, Alessandro S, Roberto C, Giovanni B, Stefano T, et al.: Primary breast lymphomas: a multicentric experience. World J Surg Oncol 2010, 8:53. CrossRef
- Ryan G, Martinelli G, Kuper-Hommel M, et al.: Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol 2008, 19:233–241. CrossRef
- Seker M, Bilici A, Ustaalioglu BO, Yilmaz B, et al.: Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast. Arch Gynecol Obstet 2011, 284:405–409. CrossRef
- Duncan Virginia E, Reddy Vishnu VB, Jhala Nirag C, Chhieng David C, et al.: Non-Hodgkin’s lymphoma of the breast: a review of 18 primary and secondary cases. Ann Diagn Pathol 2006, 10:144–148. CrossRef
- Brustein S, Filippa DA, Kimmel M, Lieberman PH, Rosen PP: Malignant lymphoma of the breast. A study of 53 patients. Ann Surg 1987, 205:144–150. CrossRef
- Sandeep Kumar A, Nalini G, Radhika S, Ashim D, et al.: Non-Hodgkin’s lymphoma presenting as breast masses: a series of 10 cases diagnosed on FNAC. Diagn Cytopathol 2011. 10.1002/dc.21763
- Popović L, Jovanović D, Matovina-Brko G, Petrović D, Nikin Z, et al.: Primary diffuse large B-cell lymphoma of the breast. Arch Oncol 2007,17(3–4):80–82.
- Wong WW, Schild SE, Halyard MY, Schomberg PJ: Primary non-Hodgkin’s lymphoma of the breast: the Mayo Clinic experience. J Surg Oncol 2002,80(1):19–25. CrossRef
- Yetim I, Durgun Yetim T, Orhan VÖ, Güvenç D, Nazan S, et al.: Bilateral primary breast lymphoma: a rare case. J Breast Health 2011,7(3):185–187.
- Ganjoo K, Advani R, Mariappan MR, McMillan A, Horning S: Non-Hodgkin lymphoma of the breast. Cancer 2007, 110:25–30. CrossRef
- Gholam D, Bibeau F, El Weshi A, Bosq J, Ribrag V: Primary breast lymphoma. Leuk Lymphoma 2003, 44:1173–1178. CrossRef
- Ha CS, Dubey P, Goyal LK, et al.: Localized primary non- Hodgkin’s lymphoma of the breast. Am J Clin Oncol 1998, 21:376–380. CrossRef
- Kuper-Hommel MJJ, Snijder S, Jansen-Heijnen ML, et al.: Treatment and survival of 38 female breast lymphomas: a population- based study with clinical and pathological reviews. Ann Hematol 2003, 82:397–404. CrossRef
- Lbrahim MH-, Singletary S: Ann. Surgical management of primary lymphoma of the breast. Ann Surg 1991,214(6):725.
- Jennings WC, Baker RS, Murray SS, et al.: Primary breast lymphoma: the role of mastectomy and the importance of lymph node status. Ann Surg 2007, 245:784–789. CrossRef
- Aviles A, Delgade S, Nambo J, et al.: Primary breast lymphoma: results of a controlled clinical trial. Oncology 2005, 69:256–260. CrossRef
- Aviles A, Castaneda C, Neri N, Cleto S, Nambo MJ: Rituximab and dose dense chemotherapy in primary breast lymphoma. Haematologica 2007, 92:1147–1148. CrossRef
- Armitage JO: How I treat patients with diffuse large B-cell lymphoma. Blood 2007, 110:29–84. CrossRef
- Fu K, Perry KD, Smith LM, et al.: Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007,25(18 Suppl):Abstr 8040.
- Lenz G, Wright G, Sandeep D, et al.: Gene expression signatures predict overall survival in diffuse large B-cell lymphoma treated with rituximab and CHOP-like chemotherapy. Blood 2007, 110:209a-Abstr 348.
- Jeanneret-Sozzi W, Taghian A, Epelbaum R, et al.: Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study. BMC Canc 2008, 8:86. CrossRef
- Primary malignant non-Hodgkin’s lymphoma of the breast: a study of seven cases and literature review
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
World Journal of Surgical Oncology
- Online Date
- July 2012
- Online ISSN
- BioMed Central
- Additional Links
- Author Affiliations
- 1. Department of Medical Oncology, National Institute of Oncology, Rabat, 10000, Morocco
- 2. Faculty of Medicine, Oujda, Morocco
- 3. Department of Surgery, National Institute of Oncology, Rabat, 10000, Morocco